| Bistability in the Rac1, PAK, and RhoA signaling network drives actin cytoskeleton dynamics and cell motility switches KM Byrne, N Monsefi, JC Dawson, A Degasperi, JC Bukowski-Wills, ... Cell systems 2 (1), 38-48, 2016 | 163 | 2016 |
| Substrate-trapped interactors of PHD3 and FIH cluster in distinct signaling pathways J Rodriguez, R Pilkington, AG Munoz, LK Nguyen, N Rauch, S Kennedy, ... Cell reports 14 (11), 2745-2760, 2016 | 95 | 2016 |
| Elevation of plasma tRNA fragments precedes seizures in human epilepsy MC Hogg, R Raoof, H El Naggar, N Monsefi, N Delanty, DF O’Brien, ... The Journal of clinical investigation 129 (7), 2946-2951, 2019 | 82 | 2019 |
| HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways J Farrell, C Kelly, J Rauch, K Kida, A Garcia-Munoz, N Monsefi, ... Journal of proteome research 13 (6), 2874-2886, 2014 | 79 | 2014 |
| BCL-2 system analysis identifies high-risk colorectal cancer patients AU Lindner, M Salvucci, C Morgan, N Monsefi, AJ Resler, M Cremona, ... Gut 66 (12), 2141-2148, 2017 | 51 | 2017 |
| Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activity A von Thun, C Preisinger, O Rath, JP Schwarz, C Ward, N Monsefi, ... Molecular and cellular biology, 2013 | 37 | 2013 |
| The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer S Carberry, B D’Orsi, N Monsefi, M Salvucci, O Bacon, J Fay, M Rehm, ... Cell death & disease 9 (2), 125, 2018 | 31 | 2018 |
| Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions L Schmidt, T Kling, N Monsefi, M Olsson, C Hansson, S Baskaran, ... Neuro-oncology 15 (11), 1469-1478, 2013 | 27 | 2013 |
| Network-based identification of feedback modules that control RhoA activity and cell migration TH Kim, N Monsefi, JH Song, A Von Kriegsheim, D Vandamme, O Pertz, ... Journal of molecular cell biology 7 (3), 242-252, 2015 | 24 | 2015 |
| 5′ ValCAC tRNA fragment generated as part of a protective angiogenin response provides prognostic value in amyotrophic lateral sclerosis MC Hogg, M Rayner, S Susdalzew, N Monsefi, M Crivello, I Woods, ... Brain Communications 2 (2), fcaa138, 2020 | 19 | 2020 |
| Computational analysis of AMPK-mediated neuroprotection suggests acute excitotoxic bioenergetics and glucose dynamics are regulated by a minimal set of critical reactions NMC Connolly, B D’Orsi, N Monsefi, HJ Huber, JHM Prehn PLoS One 11 (2), e0148326, 2016 | 14 | 2016 |
| Searching for synergies: matrix algebraic approaches for efficient pair screening P Gerlee, L Schmidt, N Monsefi, T Kling, R Jörnsten, S Nelander Plos one 8 (7), e68598, 2013 | 8 | 2013 |
| Bistability in the Rac1, PAK, and RhoA signaling network drives actin cytoskeleton dynamics and cell motility switches. Cell systems. 2016; 2 (1): 38–48 KM Byrne, N Monsefi, JC Dawson, A Degasperi, JC Bukowski-Wills, ... | 7 | |
| Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild‐type patient‐derived xenograft models of … AU Lindner, S Carberry, N Monsefi, A Barat, M Salvucci, R O'Byrne, ... International Journal of Cancer 147 (10), 2891-2901, 2020 | 5 | 2020 |
| Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre‐Clinical Detection of Off‐Target Toxicities Associated with Sunitinib Malate AC O'Farrell, IS Miller, R Evans, M Alamanou, M Cary, G Mallya Udupi, ... PROTEOMICS–Clinical Applications 13 (4), 1800159, 2019 | 5 | 2019 |
| Bistability in the Rac1, PAK and RhoA Signaling Network Drives Actin Cytoskeleton Dynamics and Cell Motility Switches. Cell Systems, 2, 38-48 KM Byrne, N Monsefi, JC Dawson, A Degasperi, JC Bukowski-Wills, ... | 5 | 2016 |
| Abstract LB-354: Investigating potential molecular biomarkers for cetuximab response in metastatic colorectal cancer tissue using reverse phase protein array N Monsefi, R O’Byrne, S Carberry, ER Zanella, A Barat, M Cremona, ... Cancer Research 76 (14_Supplement), LB-354-LB-354, 2016 | | 2016 |
| Retrospective evaluation of a system model of the BCL2 family of proteins as a predictive and prognostic biomarker for the clinical outcome of stage II-IV colorectal cancer … AU Lindner, M Salvucci, M Cremona, N Monsefi, S Curry, C Morgan, ... Cancer Research 76 (14_Supplement), 4924-4924, 2016 | | 2016 |
| Investigating potential molecular biomarkers for cetuximab response in metastatic colorectal cancer tissue using reverse phase protein array N Monsefi, R O'Byrne, S Carberry, ER Zanella, A Barat, M Cremona, ... CANCER RESEARCH 76, 2016 | | 2016 |
| A systems model of BCL-2 dependent apoptosis to predict stage II CRC patients benefiting from adjuvant chemotherapy and as a prognostic tool for stage III CRC patients with … J Prehn, AU Lindner, M Salvucci, M Cremona, N Monsefi, S Curry, ... Journal of Clinical Oncology 34 (15_suppl), 3584-3584, 2016 | | 2016 |
von KriegsheimUniversity of EdinburghVerified email at IGMM.ed.ac.uk
